Press Releases | BioSenic

Bone Therapeutics, Link Health and Pregene to develop and commercialize the ALLOB allogeneic bone cell therapy platform in China and Southeast Asia

Read more about Bone Therapeutics, Link Health and Pregene to develop and commercialize the ALLOB allogeneic bone cell therapy platform in China and Southeast Asia

Information on the total number of voting rights and shares

Read more about Information on the total number of voting rights and shares

Bone Therapeutics reports half year 2020 results

Read more about Bone Therapeutics reports half year 2020 results

Bone Therapeutics announces expansion of its pipeline supported by funding from the Walloon Region

Read more about Bone Therapeutics announces expansion of its pipeline supported by funding from the Walloon Region

Bone Therapeutics receives EUR 1.0 million to advance ongoing JTA-004 phase III knee osteoarthritis study

Read more about Bone Therapeutics receives EUR 1.0 million to advance ongoing JTA-004 phase III knee osteoarthritis study

Bone Therapeutics announces Annual General Meeting results and confirms outlook for 2020

Read more about Bone Therapeutics announces Annual General Meeting results and confirms outlook for 2020

Bone Therapeutics: Notice of Extraordinary Shareholders’ Meeting on 8 February 2021

Read more about Bone Therapeutics: Notice of Extraordinary Shareholders’ Meeting on 8 February 2021

Bone Therapeutics treats first patient in ALLOB Phase IIb tibial fracture study

Read more about Bone Therapeutics treats first patient in ALLOB Phase IIb tibial fracture study

Bone Therapeutics and Rigenerand sign partnership for cell therapy process development

Read more about Bone Therapeutics and Rigenerand sign partnership for cell therapy process development

Bone Therapeutics provides fourth quarter 2020 business update and 2021 outlook

Read more about Bone Therapeutics provides fourth quarter 2020 business update and 2021 outlook

Subscribe to Press Releases